Our data are in agreement with previous studies showing that the activation of phosphorylated GSK-3β/β-catenin activity is involved in the beneficial effects of ghrelin against hypoxia-induced pulmonary hypertension in the rat [27] and ischemic neural injury [20, 28]. Here, GSK3B is linked to pulmonary hypertension.